Development of a multilocus sequence typing scheme for Ureaplasma

J Zhang1, Y Kong, Y Feng

  • 1Clinical Laboratory, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310016, China.

Insights

A new multilocus sequence typing (MLST) scheme effectively differentiates Ureaplasma strains, revealing distinct population structures and linking specific lineages to Ureaplasma parvum and Ureaplasma urealyticum infections.

Area of Science:

  • Microbiology
  • Molecular Epidemiology
  • Genetics

Background:

  • Ureaplasma is a common human urogenital commensal.
  • It is linked to various invasive diseases, including non-gonococcal urethritis, infertility, and adverse pregnancy outcomes.
  • Understanding Ureaplasma's molecular epidemiology is crucial for disease control.

Purpose of the Study:

  • To develop and validate a multilocus sequence typing (MLST) scheme for Ureaplasma.
  • To analyze the molecular epidemiology and population structure of Ureaplasma clinical isolates.
  • To correlate genetic lineages with Ureaplasma species and clinical manifestations.

Main Methods:

  • Developed an MLST scheme using four housekeeping genes (ftsH, rpL22, valS, thrS).
  • Validated the scheme on 283 Ureaplasma isolates, including reference strains and clinical samples.
  • Employed eBURST analysis and neighbor-joining tree construction for population structure analysis.

Main Results:

  • Identified 99 unique sequence types (STs), with ST1 and ST22 being predominant.
  • Revealed two major clonal lineages (CC1 and CC2), corresponding to Ureaplasma parvum (UPA) and Ureaplasma urealyticum (UUR) respectively.
  • CC2 (UUR) was more frequently associated with symptomatic vaginitis, tubal obstruction, and cervicitis.

Conclusions:

  • The developed MLST scheme provides high discriminatory power for Ureaplasma molecular epidemiology.
  • The study elucidated distinct population structures and species-specific clonal lineages.
  • Findings highlight the potential of MLST for understanding Ureaplasma-associated diseases.